Corporate Governance25 Sept 2026, 10:28 am
Bal Pharma Closes Trading Window for Q2 FY27 Results
AI Summary
Bal Pharma Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its financial results for the second quarter ending September 30, 2026. This measure is in compliance with SEBI regulations and the company's internal code of conduct for preventing insider trading. All designated persons and their immediate relatives are prohibited from trading in the company's securities during this period. The date for the board meeting to approve these financial results will be communicated separately.
Key Highlights
- Trading window closed from October 1, 2026, for Q2 FY27 results.
- Closure is in compliance with SEBI insider trading regulations.
- Designated persons and relatives are restricted from trading.
- Specific board meeting date for results announcement to follow.
Price Impact
More from BALPHARMA